Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed makes use of Senate debate with medtech survey

This article was originally published in Clinica

Executive Summary

European regulators received higher marks than the FDA in a new survey released last week by AdvaMed. Three out of four device companies polled claimed they can get their technologies to market faster in Europe than in the US, while only 5% reported the opposite experience. The remaining 19% said there was no difference in product development times between the two jurisdictions.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel